Abstract

Despite the huge progress in the definition and classification of vestibular disorders within the last decade, there are still patients whose recurrent vestibular symptoms cannot be attributed to any of the recognized episodic vestibular syndromes, such as Menière's disease (MD), vestibular migraine (VM), benign paroxysmal positional vertigo (BPPV), vestibular paroxysmia, orthostatic vertigo or transient ischemic attack (TIA). The aim of the present international, multi-center, cross-sectional study was to systematically characterize the clinical picture of recurrent vestibular symptoms not otherwise specified (RVS-NOS) and to compare it to MD and VM. Thirty-five patients with RVS-NOS, 150 patients with VM or probable VM and 119 patients with MD were included in the study. The symptoms of RVS-NOS had been present for 5.4 years on average before inclusion, similar to VM and MD in this study, suggesting that RVS-NOS is not a transitory state before converting into another diagnosis. Overall, the profile of RVS-NOS vestibular symptoms was more similar to VM than MD. In particular, the spectrum of vestibular symptom types was larger in VM and RVS-NOS than in MD, both at group comparison and the individual level. However, in contrast to VM, no female preponderance was observed for RVS-NOS. Positional, head-motion and orthostatic vertigo were reported more frequently by patients with RVS-NOS than MD, while external vertigo was more prevalent in the MD group. At group level, the spectrum of attack durations from minutes to 3 days was evenly distributed for VM, while a small peak for short and long attacks in RVS-NOS and a big single peak of hours in MD were discernible. In general, vertigo attacks and associated vegetative symptoms (nausea and vomiting) were milder in RVS-NOS than in the other two disorders. Some patients with RVS-NOS described accompanying auditory symptoms (tinnitus: 2.9%, aural fullness and hearing loss: 5.7% each), migrainous symptoms (photophobia, phonophobia or visual aura in 5.7% each) or non-migrainous headaches (14%), but did not fulfill the diagnostic criteria for MD or VM. Absence of a life time diagnosis of migraine headache and attack duration of <5 min were further reasons not to qualify for VM. In some RVS-NOS patients with accompanying ear symptoms, attack durations of <20 min excluded them from being diagnosed with MD. These findings suggest that RVS-NOS is a stable diagnosis over time whose overall clinical presentation is more similar to VM than to MD. It is more likely to be composed of several disorders including a spectrum of mild or incomplete variants of known vestibular disorders, such as VM and MD, rather than a single disease entity with distinct pathognomonic features.

Highlights

  • The Bárány Society began to develop the International Classification of Vestibular Disorders (ICVD) in 2006 [1]

  • The main focus of this study was laid on features distinguishing recurrent vestibular symptoms not otherwise specified (RVS-NOS) from either vestibular migraine (VM), Menière’s disease (MD) or both (Table 1)

  • No statistically significant difference was observed for patients with RVS-NOS (47.16 ± 14.24 years) as compared to the other two groups (VM: p = 0.15; MD: p = 0.92)

Read more

Summary

Introduction

The Bárány Society began to develop the International Classification of Vestibular Disorders (ICVD) in 2006 [1]. Following a systematic categorization of vestibular symptoms [2], diagnostic criteria for the most common episodic vestibular disorders were published, including vestibular migraine (VM) [3], Menière’s disease (MD) [4], benign paroxysmal positional vertigo (BPPV) [5], vestibular paroxysmia (VP) [6] and hemodynamic orthostatic dizziness/vertigo [7]. Despite this huge progress in international standardization, there are still quite a number of patients whose episodic vestibular symptoms cannot be explained by these or other vestibular disorders (including, but not limited to, third-window syndromes, episodic ataxia, vertebrobasilar TIAs). While some authors defined attack duration between “minutes to hours” [11,12,13], others requested a duration between 5 min to 24 or 72 h [9, 14, 15]

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.